Convatec Group (CTEC)

Sector:

Health Care

Index:

FTSE 250

186.85p
   
  • Change Today:
    -2.25p
  • 52 Week High: 202.80
  • 52 Week Low: 118.55
  • Currency: UK Pounds
  • Shares Issued: 1,983.51m
  • Volume: 3,057,178
  • Market Cap: £3,706.20m
  • RiskGrade: 142
  • Beta: 0.72

CTEC Overview

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. Its products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. Based in Reading, it employs over 9,000 people in more than 100 countries.
Competitors: Akers Biosciences, Inc., Consort Medical, Advanced Medical Solutions

Key Personnel

Chairman: John McAdam
CEO: Karim Bitar
CFO: Frank Schulkes
Senior Independent Director: Margaret Ewing
Non-Executive Dir: Ros Rivaz , Sten Scheibye, Regina Benjamin, Rick Anderson

Contact Details

Address: 3, Forbury Place, 23 Forbury Road, Reading, United Kingdom, RG1 3JH
Website: http://www.convatecgroup.com

Listings

Sector: Health Care(LSE)
Index: FTSE 250FTSE 350FTSE All-Share
ISIN: GB00BD3VFW73

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CTEC Market Data

Currency UK Pounds
Share Price 186.85p
Change Today -2.25p
% Change -1.19 %
52 Week High 202.80
52 Week Low 118.55
Volume 3,057,178
Shares Issued 1,983.51m
Market Cap £3,706.20m
Beta 0.72
RiskGrade 142

CTEC Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
66.03% below the market average66.03% below the market average66.03% below the market average66.03% below the market average66.03% below the market average
2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average2.86% below the sector average
Price Trend
62.32% above the market average62.32% above the market average62.32% above the market average62.32% above the market average62.32% above the market average
60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average60.00% above the sector average
Income
38.8% below the market average38.8% below the market average38.8% below the market average38.8% below the market average38.8% below the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
11.93% below the market average11.93% below the market average11.93% below the market average11.93% below the market average11.93% below the market average
5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average5.88% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 8
Sell 1
Strong Sell 1
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CTEC Dividends

  Latest Previous
  Interim Final
Ex-Div 05-Sep-19 04-Apr-19
Paid 17-Oct-19 16-May-19
Amount 1.72¢ 3.98¢

Trades for 11-Dec-2019

Time Volume / Share Price
16:35 1,868,110 @ 186.85p
16:29 132 @ 187.30p
16:29 43 @ 187.20p
16:29 591 @ 187.40p
16:29 532 @ 187.40p

CTEC Key Personnel

CFO Frank Schulkes
CEO Karim Bitar
Chair John McAdam

Top of Page